Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.48 EUR
Change Today 0.00 / 0.00%
Volume 0.0
SAC On Other Exchanges
Symbol
Exchange
Xetra
Vienna
As of 11:45 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

sanochemia pharmazeutika ag (SAC) Snapshot

Open
€1.48
Previous Close
€1.48
Day High
€1.48
Day Low
€1.48
52 Week High
03/24/15 - €1.79
52 Week Low
01/23/15 - €0.92
Market Cap
19.1M
Average Volume 10 Days
7.9K
EPS TTM
--
Shares Outstanding
12.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SANOCHEMIA PHARMAZEUTIKA AG (SAC)

Related News

No related news articles were found.

sanochemia pharmazeutika ag (SAC) Related Businessweek News

No Related Businessweek News Found

sanochemia pharmazeutika ag (SAC) Details

SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients; sterile and semi-sterile liquid and semi-liquid presentations, such as antibiotics and hormones; clinical diagnostics; and veterinary pharmaceuticals, as well as radiological products, including a range of X-ray imaging agents and the MRT imaging agents. The company’s product pipeline includes Tolperisone, a centrally acting muscle relaxant; and PVP hypericine, a photoactive substance for the diagnosis and treatment of bladder carcinomas. It also researches and develops in therapeutic areas, such as painful muscle spasms/spasticity, and bladder cancer diagnostic; and offers contract manufacturing services. The company was founded in 1990 and is headquartered in Vienna, Austria.

Founded in 1990

sanochemia pharmazeutika ag (SAC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sanochemia pharmazeutika ag (SAC) Key Developments

Sanochemia Pharmazeutika AG, 2014 Earnings Call, Dec 18, 2014

Sanochemia Pharmazeutika AG, 2014 Earnings Call, Dec 18, 2014

Sanochemia Pharmazeutika AG to Report Fiscal Year 2014 Final Results on Jan 22, 2015

Sanochemia Pharmazeutika AG announced that they will report fiscal year 2014 final results on Jan 22, 2015

Sanochemia Pharmazeutika AG to Report Fiscal Year 2014 Results on Dec 18, 2014

Sanochemia Pharmazeutika AG announced that they will report fiscal year 2014 results on Dec 18, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAC:AV €1.48 EUR 0.00

SAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SAC.
View Industry Companies
 

Industry Analysis

SAC

Industry Average

Valuation SAC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOCHEMIA PHARMAZEUTIKA AG, please visit www.sanochemia.at. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.